Life Sciences Innovation
Britain has a long and proud history of Life Science innovation and is home to some of the world’s most powerful discoveries and developments. The life sciences sector is undergoing a scientific and technological revolution, from the use of AI to discover new drugs, to the mRNA platform for new vaccines and breakthroughs in gene editing, new technologies are transforming the development of new medicines and vaccines to prevent and treat disease.
In October 2024, the UK government published the Industrial Strategy Green Paper, life sciences are one of eight growth sectors that the government has identified to form part of the new ten-year industrial strategy and UK’s commitment to driving economic growth.
There are ambitious plans to modernise the NHS and make it a better innovation partner for academia and industry. The Government has already announced it has secured £400 million of private investment to boost clinical trials, creating 18 new clinical trial hubs across the UK. Around 20% of this funding will also be used to create sustainable manufacturing innovation which will enhance the UK’s global competitiveness. The NHS strategy also includes plans to harness and utilise the UK’s wealth of health data through use of digital data and AI.
Collaboration between academic institutions, funders and industry players is vital for the translation of research into practical applications. More than 5,600 life sciences businesses already operate in the UK, including all of the top 25 global pharmaceutical companies and top 30 global medical technology companies. More than 300,000 people are directly employed in the industry and the UK is also a hub for global talent.
Life Sciences Innovation will discuss the UK Government’s plans to channel significant investment into the UK’s health and life sciences sector to kickstart economic growth and give patients earlier access to new treatments.
This conference will provide the platform for attendees from the NHS, health research communities and prominent members of the life sciences sector to discuss Investment in cutting-edge medicines research, the government’s mission to kickstart economic growth and build an NHS fit for the future by helping create a thriving environment for life sciences in the UK.
Interested in the Event?
Event Speakers.
Event Schedule.
08.00 – 09.30 – Breakfast, registration and networking
09.30 – 09.40 – Chair’s welcome address
09.40 – 10.00 – Ensuring the UK is the best place to discover and deploy new medicines
Saeeda Bashir, Head of Clinical Trials Policy & Programmes, Department of Health and Social Care
10.00 – 10.20 Capturing the economic potential in life sciences
Dr Rupa Chilvers, Deputy Director for Life Sciences, Welsh Government
10:20 – 10.40 – Q&A Panel Debate
10.40 – 11.40 – Refreshments and Networking
11:40 – 12.00 – Innovation without barriers within the NHS
Joe Zhang, Head of Data Science, The AI Centre for Value Based Healthcare
12.00 – 12.20 – Clinical trials regulations reform
Jane Bentley, Board Director, The Institute of Clinical Research
12.20 – 12.40 – Population Health Management
Ian Young, Chief Scientific Advisor, Department of Health, Northern Ireland
12:40 – 13.00 – Q&A panel Debate
13:00 – 14:00 – Lunch in the Network Surgery
14.00 – 14.20 – Delivering high-quality research that saves and improves lives
Nicola Perrin MBE, Chief Executive, Association of Medical Research Charities
14.20 – 14.40 – Increasing patient access to medicines
Representative to be confirmed, Medicines UK
14.40 – 15.00 – Strengthening research innovation
David Furness, Managing Director, The Shelford Group
15:00 – 15.20 – Q&A Panel Debate
15:20 – 15.30 – Conference Close
Event Sponsors.
In Partnership With
